Susanna Gatti High, Chief Operating Officer at Dyne Therapeutics, Inc. (DYN), sold 5,492 shares at $45.01 ($248K) on 2024-08-19, disclosed to the SEC on 2024-08-20.
Scheduled sale ($248k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.01 | 2,582 | $116K | 47.0% |
| 2 | $45.01 | 2,582 | $116K | 47.0% |
| 3 | $46.00 | 328 | $15K | 6.1% |
| Total | $45.07 avg | 5,492 | $248K | 100% |
| Filing → |
| DYN | SELL | 2024-07-03 | $722K | — | Filing → |
| DYN | SELL | 2024-06-24 | $2.4M | — | Filing → |
| DYN | SELL | 2024-06-13 | $2.7M | — | Filing → |